|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Class B | |||||
| Class A | |||||
| Total net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Stock-based compensation expense | |||||
| Increase (decrease) of valuation allowance | |||||
| Deferred income taxes | |||||
| Amortization of deferred contract acquisition costs | |||||
| Gains on strategic investments, net | |||||
| Depreciation and amortization | |||||
| Provision for accounts receivable allowances | |||||
| Unrealized foreign exchange (gains) losses | |||||
| Non-cash operating lease cost | |||||
| Charitable donation of common stock | |||||
| Amortization of discount/premium on marketable securities | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Deferred contract acquisition costs | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of marketable securities | |||||
| Maturities of marketable securities | |||||
| Sales of marketable securities | |||||
| Purchases of property and equipment | |||||
| Proceeds from strategic investments | |||||
| Purchases of strategic investments | |||||
| Proceeds from sale of strategic investments | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Purchases of intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Cash paid for repurchases of common stock, including excise taxes | |||||
| Proceeds from issuance of common stock for employee stock purchase plan | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from employee equity transactions (remitted) to be remitted to employees and tax authorities, net | |||||
| Other | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash—beginning of year | |||||
| Cash, cash equivalents, and restricted cash—end of year | |||||
| Cash paid for income taxes, net | |||||
| Supplemental disclosures of non-cash investing and financing information | |||||
| Purchase of equipment during the period included in accounts payable and accrued expenses | |||||
| Excise tax on share repurchases included in accrued expenses | |||||
| Vesting of early exercised stock options | |||||
| Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above: | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current included in prepaid expenses and other current assets | |||||
| Restricted cash, noncurrent included in other assets, noncurrent | |||||
Loading...